Anticancer agent 230
Anticancer agent 230 (example 65) is a caseinolytic protease P (ClpP) activator with anticancer activity. Anticancer agent 230 is able to induce the degradation of mitochondrial proteins in SUM159 and MDA-MB-231 triple-negative breast cancer cells in a time-dependent manner[1].
Product Specifications
CAS Number
2485052-87-5
UNSPSC
12352005
Target
ClpP
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/anticancer-agent-230.html
Purity
99.97
Solubility
DMSO : 50 mg/mL (ultrasonic)
Smiles
N#CC1=CC=CC(CN(C2)CCC(N=CN3CC4=CC=C(Cl)C=C4)=C2C3=O)=C1
Molecular Formula
C22H19ClN4O
Molecular Weight
390.87
References & Citations
[1]Preparation of tetrahydropyrido[4,3-d]pyrimidine-2,4-dione analogs useful in the treatment of cancers and in modulating the activity of caseinolytic protease p function. United States, US20230339947 A1. 2023-10-26.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MR223869L4V 200 µL
Hoxb7 (NM_010460) Mouse Tagged ORF Clone Lentiviral Particle
Sign In for Pricing
View Details 
A15836-1-Fluoro594 100 µg/Vial
Anti-SEL1L2 Antibody Picoband® Fluoro594 Conjugated
Sign In for Pricing
View Details MBS1229440-01 0.02 mg (E-Coli)
Recombinant Xenopus laevis N-myc protein (mycn)
Sign In for Pricing
View Details